Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

New York Now Has a Psychedelic Athenaeum And It’s “Doors of Perception” Are Now Open | Psychedelic Spotlight

The Psychedelic Athenaeum, presented by The Psychedelic Assembly, an organization dedicated to the conversation and education of psychedelics, is a 1000 square ft. psychedelic library,

August 11, 2023

Private equity and neuroscience: a novel approach to developing new treatments for neurological disorders

Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are

July 9, 2024

Cellectis shifts CAR-T manufacturing in-house, boosts efficacy compared to third-party CDMOs: #ASH23

Allogeneic CAR-T biotech Cellectis took its CAR-T manufacturing in-house after facing “broken” supply chain issues with third party manufacturers, and, according to the company, the

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.